Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.

Liu R, Tan J, Shen X, Jiang K, Wang C, Zhu G, Xing M
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):e2022779118. doi: 10.1073/pnas.2022779118. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.